Distribution of secretory inhibitor of platelet microbicidal protein among anaerobic bacteria isolated from school of children with diarrhea

World Journal of Gastroenterology

Volumn 14, Issue 35, 2008, Pages 5428-5431

  Ivanov, Iuri B ^a   Gritsenko, Viktor A ^a  

^a INSTITUTE OF CELLULAR AND INTRACELLULAR SYMBIOSIS   (Russian Federation)

Author keywords

Anaerobic bacteria; Intestine; Platelet microbicidal protein; Secretory inhibitor

Indexed keywords

BACTERIAL PROTEIN; SECRETORY INHIBITOR OF PLATELET MICROBICIDAL PROTEIN; UNCLASSIFIED DRUG; BETA THROMBOGLOBULIN; PPBP PROTEIN, HUMAN;

ACTINOMYCES ISRAELII; ANAEROBIC BACTERIUM; ARTICLE; BACILLUS SUBTILIS; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM LONGUM; CHILD; DIARRHEA; EGGERTHELLA LENTA; HUMAN; INTESTINE FLORA; INTESTINE INFECTION; NONHUMAN; ACTINOMYCES; BACTERIAL INFECTION; BIFIDOBACTERIUM; DRUG ANTAGONISM; EUBACTERIUM; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ACTINOMYCES; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; BACTEROIDES FRAGILIS; BETA-THROMBOGLOBULIN; BIFIDOBACTERIUM; CHILD; DIARRHEA; EUBACTERIUM; FECES; HUMANS; VIRULENCE;

EID: 64849111650     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5428     Document Type: Article

References (30)

1. Finegold SM. Normal human intestinal flora. Ann Ist Super Sanita 1986; 22: 731-737
2. Finegold SM. The role of anaerobes in human infections. Scand J Infect Dis Suppl 1981; 26: 9-13
3. Briedigkeit H, Gobel U. [Anaerobic bacteria as the cause of endogenous infections] Z Arztl Fortbild Qualitatssich 1997; 91: 165-170
4. Balamurugan R, Janardhan HP, George S, Raghava MV, Muliyil J, Ramakrishna BS. Molecular studies of fecal anaerobic commensal bacteria in acute diarrhea in children. J Pediatr Gastroenterol Nutr 2008; 46: 514-519
5. Hausmann M, Rogler G. Immune-non immune networks in intestinal inflammation. Curr Drug Targets 2008; 9: 388-394
6. Durr M, Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 2002; 70: 6515-6517
7. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720
8. Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, Putsep K, Andersson M. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008; 57: 764-771
9. Wershil BK, Furuta GT. 4. Gastrointestinal mucosal immunity. J Allergy Clin Immunol 2008; 121: S380-S383; quiz S415
10. Dann SM, Eckmann L. Innate immune defenses in the intestinal tract. Curr Opin Gastroenterol 2007; 23: 115-120
11. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997; 25: 951-968; quiz 969-970
12. Ivanov IB. In vitro resistance to human platelet microbicidal protein among urethral staphylococcal and enterococcal isolates with its correlation with prostatitis. Indian J Med Microbiol 2005; 23: 253-255
13. Bukharin OV, Kagan YD, Burmistrova AL. Salmonellae and salmonelloses. Ekaterinburg: Russian Academy of Sciences, 2000; 96-102
14. Ivanov IB, Gritsenko VA, Kuzmin MD. Staphylococcal secretory inhibitor of platelet microbicidal protein is associated with prostatitis source. J Med Microbiol 2006; 55: 1645-1648
15. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-228
16. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005; 6: 551-557
17. Vaishnava S, Behrendt CL, Hooper LV. Innate immune responses to commensal bacteria in the gut epithelium. J Pediatr Gastroenterol Nutr 2008; 46 Suppl 1: E10-E11
18. Hoe NP, Vuopio-Varkila J, Vaara M, Grigsby D, De Lorenzo D, Fu YX, Dou SJ, Pan X, Nakashima K, Musser JM. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J Infect Dis 2001; 183: 633-639
19. Ganz T. Fatal attraction evaded. How pathogenic bacteria resist cationic polypeptides. J Exp Med 2001; 193: F31-F34
20. Ulvatne H, Haukland HH, Samuel sen O, Kramer M, Vorland LH. Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. J Antimicrob Chemother 2002; 50: 461-467
21. Shelburne CE, Coulter WA, Olguin D, Lantz MS, Lopatin DE. Induction of {beta}-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother 2005; 49: 183-187
22. Potempa J, Banbula A, Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 2000; 24: 153-192
23. McRedmond JP, Fitzgerald DJ. A growing set of platelet-activating bacterial proteins. Blood 2002; 99: 387-388
24. Ivanov IB, Gritsenko VA, Kuzmin MD. Distribution of secretory inhibitor of platelet microbicidal protein among urethral isolates with its correlation with prostatitis. Asian J Androl 2008; 10: 189-192
25. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 1992; 79: 369-373
26. Bukharin OV, Valyshev AV, Elagina NN. [Antilysozyme activity of anaerobic bacteria from fecal microflora in man] Zh Mikrobiol Epidemiol Immunobiol 2000; 20-22
27. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594
28. Abramzon OM, Kirillov DA, Pan'kov AS, Perunova NB, Elagina NN, Valyshev AV, Bukharin OV. [Modifying action of oxytocin on the biological properties of the causative agents of anaerobic non-clostridial infection] Zh Mikrobiol Epidemiol Immunobiol 2003; (4): 71-74
29. Kirillov DA, Chainikova IN, Perunova NB, Chelpachenko OE, Pan'kov AS, Smoliagin AI, Valyshev AV. [Effect of a polyoxydonium immunoregulator on the biological properties of microorganisms] Zh Mikrobiol Epidemiol Immunobiol 2003; (4): 74-78
30. Alekseenko SA, Krapivnaia OV, Kamalova OK, Vasiaev VIu, Pyrkh AV. [Dynamics of clinical symptoms, indices of quality of life, and the state of motor function of the esophagus and rectum in patients with functional dyspepsia and irritable bowel syndrome after Helicobacter pylori eradication] Eksp Klin Gastroenterol 2003; (4): 54-58, 115